drugset / Trial / NCT01405144

5fluorouracil for Advanced Photoaging

NCT01405144 ↗

Phase 3 Unknown 30 enrolled Federal University of São Paulo
RandomizedSingle-groupSingle-blindTreatment

Summary

It is well known the efficacy of 5% 5-fluoruracil for multiple and superficial actinic keratosis (AKs)treatment. Recently its additional benefit for advanced and severe photoaging while treating Aks was reported. The aim of this study is to compare the efficacy and safety of the two modalities of 5% 5-FU use for forearms photoaging.

Timeline

Start
2010-08
Primary completion
2011-09
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator fluorouracil Small molecule 5 % Topical